RSV: Green Book chapter updated (clesrovimab and adult risk groups)
The RSV chapter now reflects MHRA approval of clesrovimab and JCVI advice on adult risk groups.
Showing: Guidance Include news and events
Topics:Collective action & GPCContracts & fundingPCNs & neighbourhoodsVaccinations & screeningPrescribing & medicinesReferrals & hospital servicesPublic healthIT, data & cyber securityWorkforce & employmentCQC, regulation & governancePCSE & patient registrationFees & non-NHS workPremises & estatesWellbeing & supportBLMC news
The RSV chapter now reflects MHRA approval of clesrovimab and JCVI advice on adult risk groups.
Guidance for staff delivering RSV vaccination to pregnant women and older adults, now including clesrovimab.
UKHSA's summary for practitioners, with a new supporting guidance document.
Practices should revisit NHS England's standards and core contractual requirements for vaccination and immunisation services and make sure they still meet them.
The national flu immunisation programme letter for 2026/27 has been amended. Check GOV.UK for the changes.
Following ministers' acceptance of the National Screening Committee's recommendation on prostate screening, a Q&A document has been produced for GP practices.
Practices may vaccinate eligible staff registered elsewhere with MMR under INT until 30 September 2026. No item of service fee applies, but CNSGP indemnity covers it.
Cookies on this site. We’d like to use Google Analytics cookies to see which pages are used, so we can improve the site. They are not used for advertising.